Talis Biomedical Corporation (TLIS)

$9.20 0.00% $0.00 Healthcare

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

$16.76M

Mr. Robert Kelley MBA

242.00

Menlo Park, CA

Feb 12, 2021

-0.29

$-31.43

10.60

11.01

-2,197.55%

-0.04

-0.00

0.00

12.67

10.66

-18.25%

-18.51%

Similar stocks (13)

Bioventus Inc.

BVS

$6.69 -1.33%
Uptrend

Sight Sciences, Inc.

SGHT

$6.56 0.61%
Uptrend

NeuroPace, Inc.

NPCE

$6.91 5.66%
Downtrend

STRATA Skin Sciences, Inc.

SSKN

$0.37 0.38%
Downtrend

Nuwellis, Inc.

NUWE

$0.26 -5.11%
Downtrend

Vapotherm, Inc.

VAPO

$0.76 -8.83%
Downtrend

Heart Test Laboratories, Inc.

HSCS

$5.50 -19.24%
Downtrend

INVO Bioscience, Inc.

INVO

$0.86 -4.09%
Downtrend

Tenon Medical, Inc.

TNON

$0.70 -0.10%
Downtrend

Tivic Health Systems, Inc.

TIVC

$0.41 0.19%
Downtrend

Bone Biologics Corporation

BBLG

$1.66 6.41%
Downtrend

Bluejay Diagnostics, Inc.

BJDX

$0.53 3.92%
Downtrend

Motus GI Holdings, Inc.

MOTS

$0.18 9.76%
Downtrend

ETF Exposure (5)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$128.59 0.27%
Neutral

Vanguard Total Stock Market Index Fund

VITSX

0%

$126.75 0.74%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$260.44 0.77%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$126.73 0.74%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$169.62 0.38%
Uptrend